Newsroom

Verantos enables high-validity RWE for “soft outcomes” in migraine

Publications

Lundbeck, a Verantos customer, will present a poster on migraine outcomes at the American Academy of Neurology 2023 Annual Meeting on the "Development and validation of a novel model for characterizing migraine outcomes within electronic health records utilizing artificial intelligence.” Session: P8: Headache: Innovation, Quality and Technology Time: Tuesday, April 25 from 11:45 AM - 12:45 PM

Read at the original outlet
All news
Get started

Ready to advance your evidence program?

Speak with our team about how the Verantos pharmacoepidemiology stack can accelerate your timeline.